Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
QARZIBA Inf Konz 20.25 mg/4.5ml Durchstf 4.5 ml
Drug
Qarziba, Konzentrat zur Herstellung einer Infusionslösung
Neuroblastoma
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
4/18/2024
4/17/2029
Dosage strength
Qarziba 20,25 mg/4,5 ml, Konzentrat zur Herstellung einer Infusionslösung
Neuroblastoma
01
Z – approved
Package
7680674630012
No information made available
A/R – Authorised / referenced
1 bottle(s)
001
Z – approved
Declaration
Component
20.25 mg dinutuximabum beta
saccharum
histidinum
polysorbatum 20
acidum hydrochloridum
aqua ad iniectabile
histidinum
polysorbatum 20
acidum hydrochloridum
aqua ad iniectabile
Authorisation holder
7601001352742
Medius AG
Neue Bahnhofstrasse 160
4132 Muttenz (BL)
Neue Bahnhofstrasse 160
4132 Muttenz (BL)
Date of revision of the text
6/7/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.